一种碳中的罗达胺产生酸酸为光免疫疗法
Lei Yin1, Bei Zhao2, Jie Zhou3
1State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of Chemical Biology, School of Pharmacy, East China University of Science and Technology, Shanghai, 200237, China.
Angewandte Chemie (International ed. in English)
|April 21, 2024
概括
一种新的光免疫疗法方法使用光激活分子 (NPCD565) 来产生酸氧碳酸盐 (ONOOCO2-). 这触发了癌细胞死亡,并刺激了免疫反应,提供了一个有前途的新癌症治疗策略.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 光免疫疗法通过诱导免疫细胞死亡 (ICD) 提供了一个有前途的癌症治疗策略.
- 使用氧化物种的传统方法可能会导致附带组织损伤.
- 后代激素强化是一种潜在的解决方案,可以提高ICD的有效性和安全性.
研究的目的:
- 开发一种新型的光触发分子供体 (NPCD565) 用于尼特罗斯氧碳酸盐 (ONOOCO2-) 产生.
- 评估NPCD565在癌症免疫治疗中的治疗潜力.
- 研究ICD诱导和免疫反应激活的机制.
主要方法:
- 开发NPCD565,这是ONOOCO2-的分子供体.
- 在4T1细胞中NPCD565的光解和损伤相关分子模式 (DAMPs) 的评估.
- 通过树突细胞成熟试验评估免疫性.
- 在体内研究使用双边瘤携带的小鼠模型.
主要成果:
- 在广泛光谱的光照射后,NPCD565成功释放了ONOOCO2-.
- 在4T1细胞中引起光解的DAMP,证实了ICD.
- 激活的树突细胞表现出增强的成熟,表明免疫性.
- 在体内,NPCD565表现出强大的原发性瘤杀伤和远程瘤生长抑制.
结论:
- 二氧化碳酸 (ONOOCO2-) 对癌症治疗具有强大的免疫性.
- NPCD565作为一个可靠的照片触发的捐赠者ONOOCO2-,与一个内置的记者监控.
- NPCD565显示出在癌症治疗中推进光免疫疗法的巨大潜力.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Respiratory Regulation of Acid-Base Balance
2.3K
Respiratory compensation is a vital physiological process that stabilizes blood plasma pH by regulating the partial pressure of carbon dioxide (PCO2), a key determinant of pH levels. Most carbon dioxide in the blood dissolves and converts into carbonic acid (H2CO3). It dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3⁻). There is also an inverse relationship between PCO2 and pH.
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
When carbon dioxide levels increase in the blood, more H+ and HCO3⁻ are...
2.3K


